p53, bcl-2, and Bax Expression in Renal Cell Carcinoma - immunohistochemical detection of p53 protein versus clinicopathologic parameters

Author： Vasavada S.P.   Novick A.C.   Williams B.R.G.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.51, Iss.6, 1998-06, pp. : 1057-1061

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma

By Uchida T.   Gao J.-P.   Wang C.   Jiang S.-X.   Muramoto M.   Satoh T.   Minei S.   Shimura S.   Irie A.   Kameya T.   Baba S.  

Urology, Vol. 59, Iss. 4, 2002-04 ,pp. : 615-620

Elsevier

Access to resources Recommend Favorite

p53 Expression in Correlation to Clinical Outcome in Patients with Renal Cell Carcinoma

By Ljungberg B.   Bozoky B.   Kovacs G.   Stattin P.   Farrelly E.   Nylander K.   Landberg G.  

Scandinavian Journal of Urology and Nephrology, Vol. 35, Iss. 1, 2001-01 ,pp. : 15-20

Informa Healthcare

Access to resources Recommend Favorite

Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer

By Linjawi A.   Kontogiannea M.   Halwani F.   Edwardes M.   Meterissian S.  

Journal of the American College of Surgeons, Vol. 198, Iss. 1, 2004-01 ,pp. : 83-90

Elsevier

Access to resources Recommend Favorite

p53 and HER-2 alterations in renal cell carcinoma

By Zhang X.-H.   Takenaka I.   Sato C.   Sakamoto H.  

Urology, Vol. 50, Iss. 4, 1997-10 ,pp. : 636-642

Elsevier

Access to resources Recommend Favorite

Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma

By Rioux-Leclercq N.   Turlin B.   Bansard J.-Y.   Patard J.-J.   Manunta A.   Moulinoux J.-P.   Guille F.   Ramee M.-P.   Lobel B.  

Urology, Vol. 55, Iss. 4, 2000-04 ,pp. : 501-505

Elsevier

Access to resources Recommend Favorite